Observation of a Bone Invasion Model of Aspergillus fumigatus In Vitro and Analysis of the Antifungal Susceptibility

被引:0
|
作者
Shao, Yan [1 ]
Shen, Min [2 ]
Peng, Dan [2 ]
Cheng, Wenxu [2 ]
Mao, Chenggang [2 ]
Zhang, Heng [3 ]
Sun, Yi [3 ]
机构
[1] Yangtze Univ, Dept Orthoped, Jingzhou Hosp, Jingzhou, Hubei, Peoples R China
[2] Yangtze Univ, Jingzhou Hosp, Dept Otolaryngol Head & Neck Surg, Jingzhou, Hubei, Peoples R China
[3] Yangtze Univ, Jingzhou Hosp, Dept Neurosurg, Jingzhou 434020, Hubei, Peoples R China
关键词
Aspergillus fumigatus; Osteolytic; Invasive; Fungal infection; Antifungal drug; FUNGAL SINUSITIS; DIAGNOSIS;
D O I
10.1007/s11046-023-00817-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Recently, the prevalence of invasive fungal infections has been on the rise, and one of the prevalent symptoms frequently observed is bone deterioration and bone loss.Materials and Methods Using an in vitro model we studied how Aspergillus fumigatus invades the bone. Pathological analysis was then employed to observe the structure and distinctive features of the invading fungal elements within the bone invasion model. Meanwhile, the antifungal effects of itraconazole, voriconazole, posaconazole, and amphotericin B were evaluated.Results The pathological findings showed that in the experimental group, fungal spores and hyphae invaded the bone tissue or were observed growing in the vicinity of the bone edge tissues, as indicated by both HE and PAS staining. In contrast, no fungal elements were observed in the control group, indicating that the in vitro bone invasion model of A. fumigatus was successfully constructed. Furthermore, the findings from the antifungal sensitivity test demonstrated that the lowest effective concentrations of antifungal drugs against the bone invasion model were as follows: 4 mu g/ml for itraconazole, 0.5 mu g/ml for voriconazole, 2 mu g/ml for posaconazole, and 2 mu g/ml for amphotericin B.Discussion The successful construction of the bone invasion model of A. fumigatus has provided a solid basis for future investigations into the mechanisms underlying A. fumigatus bone invasion and the study of its virulence factors. Utilizing bone models is of utmost importance in advancing the development of novel antifungal treatment approaches, as well as in effectively preventing and treating fungal bone invasion and osteolytic diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Aspergillus fumigatus Forms Biofilms with Reduced Antifungal Drug Susceptibility on Bronchial Epithelial Cells
    Seidler, Marc J.
    Salvenmoser, Stefanie
    Mueller, Frank-Michael C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 4130 - 4136
  • [22] Secondary metabolite profiles and antifungal drug susceptibility of Aspergillus fumigatus and closely related species, Aspergillus lentulus, Aspergillus udagawae, and Aspergillus viridinutans
    Tamiya, Hiroyuki
    Ochiai, Eri
    Kikuchi, Kazuyo
    Yahiro, Maki
    Toyotome, Takahito
    Watanabe, Akira
    Yaguchi, Takashi
    Kamei, Katsuhiko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (5-6) : 385 - 391
  • [23] In vitro Susceptibility of Clinical Aspergillus Species to Some Antifungal Agents
    Bahkali, Ali H.
    Elgorban, Abdallah M.
    El-Samawaty, Abd El-Rahim M. A.
    Almogren, Huda-Mogren A.
    El-Metwally, Mohamed A.
    Al-Harbi, Naif S.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2015, 11 (05) : 496 - 501
  • [24] Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis:: Implications for antifungal therapy
    Hope, William W.
    Kruhlak, Michael J.
    Lyman, Caron A.
    Petraitiene, Ruta
    Petraitis, Vidmantas
    Francesconi, Andrea
    Kasai, Miki
    Mickiene, Diana
    Sein, Tin
    Peter, Joanne
    Kelaher, Amy M.
    Hughes, Johanna E.
    Cotton, Margaret P.
    Cotten, Catherine J.
    Bacher, John
    Tripathi, Sanjay
    Bermudez, Louis
    Maugel, Timothy K.
    Zerfas, Patricia M.
    Wingard, John R.
    Drusano, George L.
    Walsh, Thomas J.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (03): : 455 - 466
  • [25] In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus
    Chen, Peiying
    Yang, Jing
    Jin, Yuanling
    Lu, Chujie
    Feng, Zhenzhen
    Gao, Fei
    Chen, Yuan
    Wang, Fuling
    Shang, Zhuo
    Lin, Wei
    JOURNAL DE MYCOLOGIE MEDICALE, 2023, 33 (02):
  • [26] In Vitro Antifungal Activity and Mode of Action of 2′,4′-Dihydroxychalcone against Aspergillus fumigatus
    Seo, Young Ho
    Kim, Sung-Su
    Shin, Kwang-Soo
    MYCOBIOLOGY, 2015, 43 (02) : 150 - 156
  • [27] In vitro activity of a new antifungal azolyl-substituted indole against Aspergillus fumigatus
    Pagniez, F
    Le Borgne, M
    Marchand, P
    Na, YM
    Le Baut, G
    Robert-Piessard, S
    Le Pape, P
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (06) : 425 - 429
  • [28] The metal chaperone protein MtmA plays important roles in antifungal drug susceptibility in Aspergillus fumigatus
    Zhai, Pengfei
    Ma, Yinyan
    Du, Wenlong
    Lu, Ling
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [29] Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
    Ramondenc, I
    Pinel, C
    Ambroise-Thomas, P
    Grillot, R
    MEDICAL MYCOLOGY, 1998, 36 (02) : 69 - 73
  • [30] Hydrocortisone, prednisolone and dexamethasone act on Aspergillus fumigatus in vitro susceptibility to itraconazole.
    Ramondenc, I
    Pinel, C
    Parat, S
    Ambroise-Thomas, P
    Grillot, R
    MICROBIOS, 2001, 104 (407) : 17 - 26